You are correct. PEP-11 approval is not a pre-condition of MMR being re-instated on the ASX.
Conventional thinking was that with approval a CR for MMR would have seen a stampede, even raising at a higher price.
The proposed CR, which is a pre-condition of listng is being done at a higher price to previous CR. .005 cents per share and only one option for 2 shares.
I fully expect that the rights issue will be fully suscribed, if not instos and sophs will take up the rest.
You are correct. PEP-11 approval is not a pre-condition of MMR...
Add BPH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $25.24M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 96181 | 2.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 3000 | 1 |
View Market Depth
| Last trade - 16.27pm 09/08/2024 (20 minute delay) ? |
| BPH (ASX) Chart |
Day chart unavailable